glp 1 and menopause GLP-1s, Obesity, Menopause: Benefits and Risks GLP-1 + HRT: Why This

The treatment is administered through direct injection into muscle tissue, typically in the upper arm, thigh, hip, or buttocks area [5]

Melanotan 1 (also known as Afamelanotide) is a linear peptide

While gastroparesis raises concerns, no confirmed increased aspiration risk has been established

When used as part of CagriSema, the dosing schedule looked like this in trials: Weeks 04: 0.25 mg cagrilintide + 0.25 mg semaglutide Weeks 48: 0.5 mg + 0.5 mg Weeks 812: 1 mg + 1 mg Weeks 1216: 1.7 mg + 1.7 mg Week 16 onward: 2.4 mg + 2.4 mg (full maintenance dose) Until the medication is approved and prescribing information is finalized, any dosing decisions would only happen through participation in a clinical trial or, eventually, under the guidance of a healthcare provider

It is not a new discovery or a speculative compound

& Trombley, P